Invention Grant
US07671023B2 Amylin agonist for treating depression, anxiety disorder and schizophrenia
失效
用于治疗抑郁症，焦虑障碍和精神分裂症的胰岛淀粉样多肽激动剂
- Patent Title: Amylin agonist for treating depression, anxiety disorder and schizophrenia
- Patent Title (中): 用于治疗抑郁症，焦虑障碍和精神分裂症的胰岛淀粉样多肽激动剂
-
Application No.: US11910206Application Date: 2006-03-31
-
Publication No.: US07671023B2Publication Date: 2010-03-02
- Inventor: Kevin D. Laugero , Michael R. Hanley , Christine M. Mack , David G. Parkes , Andrew A. Young
- Applicant: Kevin D. Laugero , Michael R. Hanley , Christine M. Mack , David G. Parkes , Andrew A. Young
- Applicant Address: US CA San Diego
- Assignee: Amylin Pharmaceuticals, Inc.
- Current Assignee: Amylin Pharmaceuticals, Inc.
- Current Assignee Address: US CA San Diego
- International Application: PCT/US2006/012601 WO 20060331
- International Announcement: WO2006/105527 WO 20061005
- Main IPC: A61K38/00
- IPC: A61K38/00 ; A01N37/18
Abstract:
Methods and compositions for treating psychiatric diseases and disorders are disclosed. The methods provided generally involve the administration of an amylin or an amylin agonist to a subject in order to treat psychiatric diseases and disorders, and conditions associated with psychiatric diseases and disorders.
Public/Granted literature
- US20080287355A1 Amylin and Amylin Agonists For Treating Psychiatric Diseases and Disorders Public/Granted day:2008-11-20
Information query
IPC分类:
